Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients

NCT01169870 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER_GOV

Sponsor class

Stopped withdrawn studies

Conditions

Breast Cancer

Interventions

DRUG: Genexol-PM
DRUG: Paclitaxel

Sponsor

National Cancer Center, Korea